arrow_back Back to App

Drug Discounts Extended to Hospitals in US Territories: Improving Healthcare Access.

This bill extends the federal 340B drug discount program to hospitals in US territories, including Guam and the Virgin Islands, that serve a high volume of low-income patients. These hospitals will now be able to purchase outpatient prescription drugs at significantly reduced prices. This change aims to improve the affordability and availability of essential medications for residents in these territories.
Key points
Hospitals in US territories (Northern Mariana Islands, Guam, American Samoa, Virgin Islands) are now eligible for the 340B drug discount program.
The program provides substantial savings on prescription drugs, helping these hospitals better serve low-income populations and potentially expand healthcare services.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_9127
Sponsor: Del. Sablan, Gregorio Kilili Camacho [D-MP-At Large]
Process start date: 2024-07-24
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Equitable Access to 340B Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_9127.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-07-24.

What are the main provisions?

Key points include:

  • Hospitals in US territories (Northern Mariana Islands, Guam, American Samoa, Virgin Islands) are now eligible for the 340B drug discount program.
  • The program provides substantial savings on prescription drugs, helping these hospitals better serve low-income populations and potentially expand healthcare services.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Del. Sablan, Gregorio Kilili Camacho [D-MP-At Large].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health